Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adial Pharmaceuticals

0.2390
-0.0016-0.67%
Post-market: 0.25160.0126+5.27%19:59 EDT
Volume:4.02M
Turnover:984.95K
Market Cap:2.08M
PE:-0.15
High:0.2611
Open:0.2500
Low:0.2200
Close:0.2406
Loading ...

Adial Pharmaceuticals Completes $3.6M Public Offering

TIPRANKS
·
10 hours ago

Adial Pharmaceuticals prices 11.1M shares at 32.51c in public offering

TIPRANKS
·
17 Jun

Adial Pharmaceuticals Announces Pricing of $3.6 Million Public Offering

THOMSON REUTERS
·
17 Jun

Adial Pharmaceuticals Reschedules 2025 Annual Meeting Date

TIPRANKS
·
17 Jun

Adial Pharmaceuticals Inc - FDA Reschedules End of Phase 2 Meeting to July 29

THOMSON REUTERS
·
16 Jun

Adial Pharmaceuticals Submits Briefing Package to Guide Upcoming FDA Meeting

THOMSON REUTERS
·
16 Jun

Adial Pharmaceuticals Advances Toward Phase 3 Development for Ad04

THOMSON REUTERS
·
11 Jun

Adial Pharmaceuticals files to sell 7.59M shares of common stock, warrants

TIPRANKS
·
06 Jun

Adial Pharmaceuticals files to sell 6.73M shares of common stock for holders

TIPRANKS
·
31 May

Adial Pharmaceuticals Inc. Faces Nasdaq Delisting Risk Due to Noncompliance with Listing Rule

Reuters
·
31 May

Adial Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
17 May

Adial Pharmaceuticals Q1 EPS $(0.34) Beats $(0.50) Estimate

Benzinga
·
15 May

Adial Pharmaceuticals Reports Q1 2025 Results: Net Loss Narrows to $2.2M, Driven by Reduced Inducement Expense

Reuters
·
15 May

Adial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

THOMSON REUTERS
·
15 May

Adial Pharmaceuticals Q1 Net Income USD -2.2 Million

THOMSON REUTERS
·
15 May

Adial Pharmaceuticals Inc expected to post a loss of 49 cents a share - Earnings Preview

Reuters
·
15 May

Adial Pharmaceuticals Receives Milestone Payment From Adovate Following Initiation of Phase 1 Study

THOMSON REUTERS
·
13 May

Adial Pharmaceuticals Inc expected to post a loss of 49 cents a share - Earnings Preview

Reuters
·
10 May

BRIEF-Adial Pharmaceuticals Granted End Of Phase 2 Meeting From FDA

Reuters
·
08 May

Adial Pharmaceuticals Inc - FDA Meeting Scheduled for July 25, 2025

THOMSON REUTERS
·
08 May